Nextgen Biomed Ltd NXGN:Tel Aviv Stock Exchange

*Data is delayed | Exchange | ILS
Last | 2:02 PM EEST
108.00quote price arrow up+3.50 (+3.34%)
Volume
17,857
52 week range
95.00 - 159.00
Loading...
  • Open100.00
  • Day High118.00
  • Day Low100.00
  • Prev Close108.20
  • 52 Week High159.00
  • 52 Week High Date01/01/24
  • 52 Week Low95.00
  • 52 Week Low Date02/22/24

Key Stats

  • Market Cap2.3M
  • Shares Out7.43M
  • 10 Day Average Volume86,852.5
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-26.78

KEY STATS

  • Open100.00
  • Day High118.00
  • Day Low100.00
  • Prev Close108.20
  • 52 Week High159.00
  • 52 Week High Date01/01/24
  • 52 Week Low95.00
  • 52 Week Low Date02/22/24
  • Market Cap2.3M
  • Shares Out7.43M
  • 10 Day Average Volume86,852.5
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-26.78

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Nextgen Biomed Ltd

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Nextgen Biomed Ltd is an Israel-based research and development company. Its main activity is to own EyePen product. The Company's product is dedicated to people with diabetes and consists of an injection module which allows to monitor the doses and time of insulin intake. The EyePen mobile app keeps diabetes management systematic by monitoring behavior and provides alerts for human errors such as forgetting a pen, double insulin injections, or skipping injections.
Jacob Amidror
Chairman of the Board
Yaniv Hevron
Chief Executive Officer, Director
Oren Attiya
Chief Financial Officer
Address
Oppenheimer 7
Rehovot
7670107
Israel